CN1096953A - A kind of Chinese medicine for the treatment of osteoporosis - Google Patents
A kind of Chinese medicine for the treatment of osteoporosis Download PDFInfo
- Publication number
- CN1096953A CN1096953A CN93107842A CN93107842A CN1096953A CN 1096953 A CN1096953 A CN 1096953A CN 93107842 A CN93107842 A CN 93107842A CN 93107842 A CN93107842 A CN 93107842A CN 1096953 A CN1096953 A CN 1096953A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- osteoporosis
- medicine
- treatment
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 35
- 208000001132 Osteoporosis Diseases 0.000 title claims abstract description 18
- 239000000796 flavoring agent Substances 0.000 claims abstract description 7
- 235000019634 flavors Nutrition 0.000 claims abstract description 7
- 229940079593 drug Drugs 0.000 claims abstract description 6
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 3
- 150000001669 calcium Chemical class 0.000 claims abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 230000000694 effects Effects 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 102000055006 Calcitonin Human genes 0.000 description 4
- 108060001064 Calcitonin Proteins 0.000 description 4
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 4
- 229960004015 calcitonin Drugs 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000008676 import Effects 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 208000008035 Back Pain Diseases 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- XQRLCLUYWUNEEH-UHFFFAOYSA-L diphosphonate(2-) Chemical compound [O-]P(=O)OP([O-])=O XQRLCLUYWUNEEH-UHFFFAOYSA-L 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 206010030247 Oestrogen deficiency Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 208000012991 uterine carcinoma Diseases 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A kind of Chinese medicine for the treatment of osteoporosis is a kind of special-purpose Chinese medicine that tallies with the national condition that enriches the natural resources of Chinese medicinal materials development that utilizes motherland.By Radix Rehmanniae Preparata (Radix Rehmanniae Preparata), Fructus Corni, Rhizoma Dioscoreae, Rhizoma Alismatis, Cortex Moutan, Poria, Rhizoma Cibotii, Radix Angelicae Sinensis, Herba Epimedii (Herba Epimedii), Concha Ostreae (activated calcium) totally 10 the flavor medicines form, the shared ratio of each medicine of distinguishing the flavor of is 2: 1: 1: 0.75: 0.75: 0.75: 1: 1: 0.5: 0.25.This Chinese medicine is mainly used to treat constitutional and secondary osteoporosis, and can be used as the medication of union of fracture phase.
Description
The present invention relates to a kind of Chinese medicine, particularly a kind of Chinese medicine for the treatment of osteoporosis.
Osteoporosis is a kind of common disease that occurs along with increasing age, and along with the arriving of world population aging, osteoporosis and the fracture sickness rate that is caused by osteoporosis are increasing sharply.The worldwide disease that at present should disease have become the serious harm human health.The main medicine of external this disease of treatment at present has calcitonin, fluoride preparation, Diphosphonate preparation etc.Owing to reasons such as there are the medicine supply shortage in these medicines, cost an arm and a leg, the life-time service curative effect is dissatisfied, side effect is bigger, be extensive use of in China and also have many difficulties.China starts late to the research of this disease, at present the still untapped special-purpose medicaments that goes out to treat osteoporosis.
The objective of the invention is to overcome the deficiency of above-mentioned prior art, utilize the natural resources of Chinese medicinal materials of China's abundant, a kind of Chinese medicine of the treatment osteoporosis that tallies with the national condition is provided, thereby fill up China's blank in this respect.
Order Pi of the present invention be achieved in that this Chinese medicine by Radix Rehmanniae Preparata (Radix Rehmanniae Preparata), Fructus Corni, Rhizoma Dioscoreae, Rhizoma Alismatis, Cortex Moutan, Poria, Rhizoma Cibotii, Radix Angelicae Sinensis, Herba Epimedii (Herba Epimedii), Concha Ostreae (activated calcium) totally 10 the flavor medicines form.The shared ratio of the above-mentioned medicine of respectively distinguishing the flavor of is 2: 1: 1: 0.75: 0.75: 0.75: 1: 1: 0.5: 0.25.
This Chinese medicine can be used to the deficient syndrome of nourishing the liver and kidney based on nourishing the liver and kidney, strong bone, adjusting function of human body, reaches to strengthen the function of human body activity, make QI and blood sufficient gradually, negative and positive are able to balance, eliminate or improve the various deficient weak disease of bone, thereby reach the purpose of treatment osteoporosis.
The Chinese medicine that this prescription is formed is compared with above-mentioned external Western medicine has lot of advantages.1, medicine source wide material sources, medicine is with low cost.For example: import Western medicine calcitonin 10 units/, 50～70 yuan of prices, 3 times weekly, 3 months expense of logotype is up to 2000 yuan.And used this treatment by Chinese herbs 3 months, its expense is about 200 yuan.2, therapeutic domain is wider.The import Western medicine only is better to the osteoporosis therapy effect of a certain type, and for example calcitonin is used for the patients with osteoporosis with fresh fracture more, and estrogen then is used for causing osteoporosis because of estrogen deficiency after the menopause.This Chinese medicine then can be used for the osteoporosis that above various different reasons cause.3, various toxicity, side effects are little.Import Western medicine life-time service, the toxicity, side effect incidence rate is higher, and for example life-time service Diphosphonate preparation can cause the lower limb pain syndrome; After the calcitonin injection, patient has the hectic fever sense, and estrogenic life-time service may cause the rising of women's uterus carcinoma, breast cancer incidence.This Chinese medicine does not then have these toxicity, side effects, and zoopery has also confirmed this point.4, curative effect is reliable.The part osteoporosis patient that used this treatment by Chinese herbs, the lumbar and back pain symptom is clearly better after 90.7% the patient, and the detection index of every bone is improved.
When producing this Chinese medicine, as long as the above-mentioned medicine of respectively distinguishing the flavor of is assorted in proportion, through fine ground, get final product in incapsulating after sieving.This Chinese medicine is mainly used to treat constitutional and secondary osteoporosis, and can be used as the medication of union of fracture phase.
Claims (1)
1, a kind of Chinese medicine for the treatment of osteoporosis is characterized in that: by Radix Rehmanniae Preparata (Radix Rehmanniae Preparata), Fructus Corni, Rhizoma Dioscoreae, Rhizoma Alismatis, Cortex Moutan, Poria, Rhizoma Cibotii, Radix Angelicae Sinensis, Herba Epimedii (Herba Epimedii), Concha Ostreae (activated calcium) totally 10 the flavor medicines form; The shared ratio of each medicine of distinguishing the flavor of is 2: 1: 1: 0.75: 0.75: 0.75: 1: 1: 0.5: 0.25.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN93107842A CN1038813C (en) | 1993-07-02 | 1993-07-02 | Traditional Chinese medicine for treating osteoporosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN93107842A CN1038813C (en) | 1993-07-02 | 1993-07-02 | Traditional Chinese medicine for treating osteoporosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1096953A true CN1096953A (en) | 1995-01-04 |
| CN1038813C CN1038813C (en) | 1998-06-24 |
Family
ID=4986898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN93107842A Expired - Lifetime CN1038813C (en) | 1993-07-02 | 1993-07-02 | Traditional Chinese medicine for treating osteoporosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1038813C (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1055853C (en) * | 1996-01-25 | 2000-08-30 | 地方国营哈尔滨制药六厂 | Chinese drug for osteoporosis and the preparation thereof |
| WO2003105829A1 (en) * | 2002-06-18 | 2003-12-24 | Shanghai Institute Of Pharmaceutical Industry | A formulation of traditional chinese medicine for preventing and treating osteoporosis |
| WO2004052120A1 (en) * | 2002-12-06 | 2004-06-24 | Shanghai Sundise Chinese Medicine Technology Development Co., Ltd. | A healthy food for increasing bone density and anti-aging |
| CN1327851C (en) * | 2005-10-12 | 2007-07-25 | 郭斌阁 | Preparation process of hepatic cell growth promotion protein and its injection preparation method |
| CN101361893B (en) * | 2008-09-16 | 2010-11-03 | 东莞市赫尔逊生物科技有限公司 | Traditional Chinese medicine combination for preventing and treating osteoporosis |
| CN101485778B (en) * | 2009-03-03 | 2011-03-16 | 中国人民解放军第四军医大学 | Capsule prescription containing prepared rehmannia root and oyster and preparation method thereof |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1330350C (en) * | 2005-01-05 | 2007-08-08 | 李毅 | Calcium-tonifying bone-strengthening medicine and preparation method thereof |
| CN1319573C (en) * | 2006-03-10 | 2007-06-06 | 邯郸制药有限公司 | Chinese medicine composition for treating osteoporosis and preparing method |
| CN101143185B (en) * | 2007-07-18 | 2011-05-04 | 广州中医药大学 | Medicinal composition capable of anti-senility during menopausal syndrome |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1047082C (en) * | 1992-05-15 | 1999-12-08 | 北京蓉生医药科技发展中心 | Process of preparation of medicine tonifying kidney and bone |
| CN1069654A (en) * | 1992-06-30 | 1993-03-10 | 时光达 | Kedney and bone cure tablet compound method and purposes |
-
1993
- 1993-07-02 CN CN93107842A patent/CN1038813C/en not_active Expired - Lifetime
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1055853C (en) * | 1996-01-25 | 2000-08-30 | 地方国营哈尔滨制药六厂 | Chinese drug for osteoporosis and the preparation thereof |
| WO2003105829A1 (en) * | 2002-06-18 | 2003-12-24 | Shanghai Institute Of Pharmaceutical Industry | A formulation of traditional chinese medicine for preventing and treating osteoporosis |
| WO2004052120A1 (en) * | 2002-12-06 | 2004-06-24 | Shanghai Sundise Chinese Medicine Technology Development Co., Ltd. | A healthy food for increasing bone density and anti-aging |
| CN1327851C (en) * | 2005-10-12 | 2007-07-25 | 郭斌阁 | Preparation process of hepatic cell growth promotion protein and its injection preparation method |
| CN101361893B (en) * | 2008-09-16 | 2010-11-03 | 东莞市赫尔逊生物科技有限公司 | Traditional Chinese medicine combination for preventing and treating osteoporosis |
| CN101485778B (en) * | 2009-03-03 | 2011-03-16 | 中国人民解放军第四军医大学 | Capsule prescription containing prepared rehmannia root and oyster and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1038813C (en) | 1998-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100356972C (en) | Chinese medicine for treating amblyopia and myopia | |
| CN103349753A (en) | Traditional Chinese medicine composition for treating kidney deficiency | |
| CN1312102A (en) | Life essence-filling, marrow-benefitting and kidney invigorating Chinese medicine preparation | |
| CN100460008C (en) | Chinese medicine composition for treating cancer | |
| CN1038813C (en) | Traditional Chinese medicine for treating osteoporosis | |
| CN101837112B (en) | Chinese medicinal composition for curing irregular menstrual period and preparation method thereof | |
| CN101181449A (en) | Medicine liqueur for curing osteoproliferation | |
| CN102274417B (en) | Chinese prepared medicament for treating aplastic anemia | |
| CN101062274A (en) | Medicine for treating amenorrhea and preparing method thereof | |
| CN1153655A (en) | Chinese medicine prepn for balancing internal secretion | |
| CN102988887A (en) | Chinese medicament for treating ovarian cyst | |
| CN1058908A (en) | Prescription of oral liquor for increasing leucocyte and manufacturing process | |
| CN105582274A (en) | Pharmaceutical composition for treating female climacteric syndrome and preparing method thereof | |
| CN1185333A (en) | Womb-warming proconceptive powder | |
| CN102078559A (en) | Chinese medicinal composition with functions of tonifying kidney and strengthening brain | |
| CN101306152B (en) | Antaiyuzi decoration | |
| CN102125645B (en) | Traditional Chinese medicine preparation for treating osteoporosis | |
| CN100540030C (en) | A kind of topical agent for the treatment of dysmenorrhes | |
| CN1348779A (en) | Chloasma eliminating medicine | |
| CN1072855A (en) | Prevent and treat climacteric syndrome medicaments preparation method | |
| CN101675961B (en) | A medicinal preparation for treating breast cancer and preparation method thereof | |
| CN101637539A (en) | Natural immune anti-aging agent | |
| CN1333026A (en) | Medicine for treating hyperplasia of mammary glands | |
| CN1102591A (en) | Three-seedling compound mixture and formula thereof | |
| CN1078476C (en) | Gastric cancer treating Chinese medicine preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: WUHAN JIANMIN PHARMACEUTICAL GROUP CO., LTD. Free format text: FORMER OWNER: ZHOU YONG Effective date: 20110620 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 430010 CHANGJIANG HOSPITAL, HUANGPU ROAD, HANKOU, WUHAN CITY, HUBEI PROVINCE TO: 430052 NO. 484, YINGWU AVENUE, HANYANG DISTRICT, WUHAN CITY, HUBEI PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20110620 Address after: 430052, 484 parrot Avenue, Hanyang District, Hubei, Wuhan Patentee after: Wuhan Jianmin Pharmaceutical Group Co., Ltd. Address before: 430010 Changjiang hospital, Huangpu Road, Wuhan, Hubei, Hankou Patentee before: Zhou Yong |
|
| C17 | Cessation of patent right | ||
| CX01 | Expiry of patent term |
Expiration termination date: 20130702 Granted publication date: 19980624 |